Comparison of the ability of adeno-associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate efficient transduction of the liver in murine and nonhuman primate models

This publication has 34 references indexed in Scilit:

• Immune Responses to Recombinant Adeno-Associated Virus Vectors: Putting Preclinical Findings into Perspective
  Human Gene Therapy, 2004
• 1002. Immune Responses to AAV and to Factor IX in a Phase I Study of AAV-Mediated, Liver-Directed Gene Transfer for Hemophilia B
  Molecular Therapy, 2004
• Preclinical in vivo evaluation of pseudotyped adeno-associated virus vectors for liver gene therapy
  Blood, 2003
• Improved Hepatic Gene Transfer by Using an Adeno-Associated Virus Serotype 5 Vector
  Journal of Virology, 2002
• Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy
  Proceedings of the National Academy of Sciences, 2002
• Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapy
  Blood, 2002
• Cross-Packaging of a Single Adeno-Associated Virus (AAV) Type 2 Vector Genome into Multiple AAV Serotypes Enables Transduction with Broad Specificity
  Journal of Virology, 2002
• Lack of Germline Transmission of Vector Sequences Following Systemic Administration of Recombinant AAV-2 Vector in Males
  Molecular Therapy, 2001
• Factors influencing in vivo transduction by recombinant adeno-associated viral vectors expressing the human factor IX cDNA
  Blood, 2001
• Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization
  Nature Medicine, 1999